Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1426.80
-11.95 (-0.83%) Cipla - Quaterly Results
Date: 25-01-2022
The December 2021 quarter revenue stood at Rs. 39547.90 millions, up 5.98% as compared to Rs. 37315.50 millions during the corresponding quarter last year.A meek growth of 4.56% was reported for the quarter ended December 2021 to Rs. 7308.30 millions from Rs. 6989.30 millions.The company reported a good operating profit of 11129.80 millions compared to 10922.70 millions of corresponding previous quarter.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202112 | 202012 | % Var | 202112 | 202012 | % Var | 202103 | 202003 | % Var | |
| Sales | 39547.90 | 37315.50 | 5.98 | 119072.30 | 106674.60 | 11.62 | 139005.80 | 126591.50 | 9.81 |
| Other Income | 730.00 | 961.20 | -24.05 | 3503.90 | 1809.50 | 93.64 | 2302.80 | 8928.50 | -74.21 |
| PBIDT | 11129.80 | 10922.70 | 1.90 | 35186.80 | 32528.10 | 8.17 | 39518.40 | 36001.40 | 9.77 |
| Interest | 55.50 | 103.30 | -46.27 | 211.50 | 362.30 | -41.62 | 450.70 | 360.50 | 25.02 |
| PBDT | 11074.30 | 10819.40 | 2.36 | 34975.30 | 32165.80 | 8.73 | 39067.70 | 35640.90 | 9.61 |
| Depreciation | 1339.50 | 1345.70 | -0.46 | 4099.00 | 4191.00 | -2.20 | 5561.10 | 5997.80 | -7.28 |
| PBT | 9734.80 | 9473.70 | 2.76 | 30876.30 | 27974.80 | 10.37 | 33506.60 | 29643.10 | 13.03 |
| TAX | 2426.50 | 2484.40 | -2.33 | 7826.60 | 7426.10 | 5.39 | 8823.80 | 6461.40 | 36.56 |
| Deferred Tax | -159.10 | -31.60 | 403.48 | -276.40 | -290.90 | -4.98 | -220.00 | 1001.80 | -121.96 |
| PAT | 7308.30 | 6989.30 | 4.56 | 23049.70 | 20548.70 | 12.17 | 24682.80 | 23181.70 | 6.48 |
| Equity | 1613.60 | 1612.90 | 0.04 | 1613.60 | 1612.90 | 0.04 | 1612.90 | 1612.50 | 0.02 |
| PBIDTM(%) | 28.14 | 29.27 | -3.86 | 29.55 | 30.49 | -3.09 | 28.43 | 28.44 | -0.03 |